MedTrace Logo

GORE® TAG® Thoracic Endoprosthesis French Mandatory Registry

NCT02266342 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 154

Last updated 2024-04-19

Study results available
· View outcomes & findings →

Summary

This is a French Registry mandated by the French National Health Authority assessing long-term (5-years) safety of the GORE® TAG® Thoracic Endoprosthesis treating diseases of the thoracic aorta.

Conditions

  • Aortic Aneurysm, Thoracic
  • Descending Thoracic Aortic Dissection
  • Aortic Diseases
  • Aorta Thoracic; Traumatic Rupture
  • Penetrating Ulcer

Interventions

DEVICE

GORE® TAG® Thoracic Endoprostheses

Endovascular therapy to treat thoracic disease

Sponsors & Collaborators

  • W.L.Gore & Associates

    lead INDUSTRY

Principal Investigators

  • Nabil Chakfé, Prof · Hôpitaux Universitaire de Strasbourg

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2021-12-31
Completion
2022-04-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02266342 on ClinicalTrials.gov